Close

The W World Corp. Plans to be Listed on NASDAQ

06-28

W World Corp., a biopharmaceutical company, announces its intention to get listed on NASDAQ on 2020/2021, opening speech by Professor Dr. OUDOM, Chairman of the W World Corp, June 28, 2020 at 0:00 a.m., New York.


W World Corp. is a globally focused biopharmaceutical company dedicated to build the global health industry chain and become a leader in the development of innovative and impactful drugs for the treatment of diseases, especially cancer diseases.


W World Corp. invests in biopharmaceutical health industry in Asia, Oceania, Australia, and Vanuatu, including the third-largest region in Europe. The company has established a long-term strategic partnership with hospitals around the world with high reputation, and started the cooperation of building 33 rehabilitation centers, striving for a new road in the field of medical treatment of cancer and other special diseases.


W World Corp. has maintained a strategic partnership with five universities in Thailand, including Royal University of South Tower, National Xi Ba Gong University, National Northeast University of Science and Technology, National Meizhou University and the National University of Technology, striving for an international breakthrough in the field of medical research, processing and extraction.


In line with the enterprise philosophy of "Serving human health all over the world", W World Corp. will be committed to building a whole health industrial chain integrating the fields of medical treatment, pharmaceutical industry, health education, and training.


免责声明:本文转载自其它媒体,转载目的在于传递更多信息,并不代表本网赞同其观点和对其真实性负责,亦不负任何法律责任。 本站所有资源全部收集于互联网,分享目的仅供大家学习与参考,如有版权或知识产权侵犯等,请给我们留言。
      联系我们   SiteMap